The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Demographics, outcomes, and risk factors for patients (Pts) with sarcoma and COVID-19: A multi-institutional cohort analysis.
 
Michael J Wagner
Consulting or Advisory Role - Adaptimmune; Deciphera; Tempus
Research Funding - Adaptimmune (Inst); Athenex (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Merck (Inst)
 
Matthew Ingham
Consulting or Advisory Role - Apexigen; Daiichi Sankyo; Xencor
Research Funding - Apexigen (Inst); Mirati Therapeutics (Inst); PTC Therapeutics (Inst)
Travel, Accommodations, Expenses - Genentech
 
Corrie Painter
Stock and Other Ownership Interests - Epizyme; Inovio Pharmaceuticals; OPKO Health; Pfizer; Roche
Other Relationship - Angiosarcoma Awareness
 
Rashmi Chugh
Consulting or Advisory Role - Deciphera; Deciphera; Ipsen
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MabVax (Inst); Medivation (Inst); Morphotek (Inst); Mundipharma (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst); Qilu Puget Sound Biotherapeutics (Inst); Qilu Puget Sound Biotherapeutics (Inst); SpringWorks Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Wolters Kluwer
Travel, Accommodations, Expenses - SpringWorks Therapeutics
 
Jonathan C. Trent
Consulting or Advisory Role - Agios; Bayer; Blueprint Medicines; C4 Therapeutics; Daiichi Sankyo; Deciphera; Epizyme; Janssen; Lilly; Novartis
 
Vivek Subbiah
Consulting or Advisory Role - Helsinn Therapeutics; Loxo; MedImmune; QED Therapeutics; R-Pharm
Research Funding - Abbvie (Inst); Agensys (Inst); Alfasigma (Inst); Amgen (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); D3 Oncology Solutions (Inst); Exelixis (Inst); Fujifilm (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Idera (Inst); Incyte (Inst); Inhibrx (Inst); LOXO (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Takeda (Inst); Turning Point Therapeutics (Inst); Vegenics (Inst)
Travel, Accommodations, Expenses - Bayer; Helsinn Therapeutics; Novartis; PharmaMar
Other Relationship - Medscape
 
Ali Raza Khaki
Stock and Other Ownership Interests - Merck; Sanofi
 
Lisa May Ling Tachiki
No Relationships to Disclose
 
Elizabeth Trice Loggers
Research Funding - Epizyme (Inst); Karyopharm Therapeutics (Inst); SpringWorks Therapeutics (Inst)
 
Chris Labaki
No Relationships to Disclose
 
Rana R. McKay
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Dendreon; Exelixis; Janssen; Merck; Novartis; Pfizer; Sanofi; Tempus; Vividion Therapeutics
Research Funding - Bayer (Inst); Pfizer (Inst); Tempus (Inst)
 
Elizabeth A. Griffiths
Honoraria - Novartis
Consulting or Advisory Role - Alexion Pharmaceuticals; Boston Scientific; Celgene/Bristol-Myers Squibb; Genentech; Newlink Genetics; Novartis; Otsuka; Partner Therapeutics; Persimmune; Taiho Oncology; Takeda
Research Funding - Apellis Pharmaceuticals (Inst); Astex Pharmaceuticals (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Celldex (Inst); Genentech (Inst)
 
Katherine Anne Thornton
Consulting or Advisory Role - Adaptimmune; Agios; deloitte; Lilly; Macrogenics; More Health
Expert Testimony - Kilcoyne & Nesbitt
Travel, Accommodations, Expenses - adaptimmune
 
Anup Kasi
Honoraria - OncLive
Research Funding - Astellas Pharma (Inst); Geistlich Pharma (Inst); Halozyme (Inst); Rafael Pharmaceuticals (Inst); TESARO (Inst)
Travel, Accommodations, Expenses - Halozyme; Rafael Pharmaceuticals
 
Clara Hwang
Stock and Other Ownership Interests - Johnson & Johnson/Janssen (I)
Consulting or Advisory Role - Genzyme
Research Funding - AstraZeneca (Inst); Bausch Health (Inst); Bayer (Inst); Genentech (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Merck
 
James Lin Chen
Consulting or Advisory Role - Syapse
Speakers' Bureau - Foundation Medicine
Research Funding - Eisai
Patents, Royalties, Other Intellectual Property - MatchTX
 
Thorvardur Ragnar Halfdanarson
Consulting or Advisory Role - Advanced Accelerator Applications (Inst); Curium Pharma; Ipsen (Inst); Lexicon (Inst); ScioScientific; TERUMO
Research Funding - Advanced Accelerator Applications (Inst); Agios (Inst); Basilea (Inst); Ipsen (Inst); Novartis (Inst); Thermo Fisher Scientific (Inst); Turnstone Bio (Inst)
 
Daniel Y. Reuben
No Relationships to Disclose
 
Cathleen Park
No Relationships to Disclose
 
Elizabeth J. Davis
Speakers' Bureau - Physicans' Education Resource
Research Funding - Actuate Therapeutics (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); TopAlliance BioSciences Inc (Inst)